Home THERAPY AREAS The rationale for raising the 25(OH)D target to >50 ng/mL in patients with ND-CKD 18 February 2022 Nephrology and Rare Diseases CKD-MBD and SHPT The rationale for raising the 25(OH)D target to >50 ng/mL in patients with ND-CKD THERE IS MORE HERE Specialist information is located in this area. In order to be able to see this, you must verify yourself as a healthcare professional. ?